Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders  

作　　者：Katherine L.Marshall Mohamed H.Farah 

机构地区：[1]Department of Neurology at Johns Hopkins School of Medicine,Baltimore,MD,USA

出　　处：《Neural Regeneration Research》2021年第10期1901-1910,共10页中国神经再生研究（英文版）

基　　金：This work was supported by the Muscular Dystrophy Association,No.W81XWH1910229(to MHF);from Department of Defense’s Congressionally Directed Medical Research Program,and Maryland Stem Cell Research Fund,No.2019-MSCRFD-5093(to MHF).

摘　　要：Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages.Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets,which in turn leads to functional impairment.During the course of many of neurologic diseases,axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function.In amyotrophic lateral sclerosis(ALS),distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death.There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course.Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy.There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration,especially in regards to motor neurons derived from patient induced pluripotent stem cells.Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons,and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations.Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration,sprouting,and reinnervation of neuromuscular junctions.In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS,and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.

关 键 词：amyotrophic lateral sclerosis axonal regeneration dying-back axonopathy in vitro neuromuscular junction iPSC-derived motor neurons microfluidic device motor axon sprouting 

分 类 号：R741[医药卫生—神经病学与精神病学]